Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial

Bridget A Graney, David H Au, Anna E Barón, Andrew Cheng, Sara A Combs, Thomas J Glorioso, Grady Paden, Elizabeth C Parsons, Borsika A Rabin, Debra P Ritzwoller, Jessica-Jean Stonecipher, Carolyn Turvey, Carolyn H Welsh, David B Bekelman, Bridget A Graney, David H Au, Anna E Barón, Andrew Cheng, Sara A Combs, Thomas J Glorioso, Grady Paden, Elizabeth C Parsons, Borsika A Rabin, Debra P Ritzwoller, Jessica-Jean Stonecipher, Carolyn Turvey, Carolyn H Welsh, David B Bekelman

Abstract

Background: People living with chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD) suffer impaired quality of life due to burdensome symptoms and depression. The Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial aims to determine the effect of a multidisciplinary, team-based intervention on quality of life in people with these common diseases.

Methods/design: The ADAPT trial is a two-site, patient-level randomized clinical trial that examines the effectiveness of the ADAPT intervention compared to usual care on patient-reported quality of life at 6 months in veterans with CHF, COPD or ILD with poor quality of life and increased risk for hospitalization or death. The ADAPT intervention involves a multidisciplinary team-a registered nurse, social worker, palliative care specialist, and primary care provider (with access to a pulmonologist and cardiologist)-who meet weekly to make recommendations and write orders for consideration by participants' individual primary care providers. The nurse and social worker interact with participants over six visits to identify and manage a primary bothersome symptom and complete a structured psychosocial intervention and advance care planning. The primary outcome is change in patient-reported quality of life at 6 months as measured by the Functional Assessment of Chronic Illness Therapy-General questionnaire. Secondary outcomes at 6 months include change in symptom distress, depression, anxiety, disease-specific quality of life hospitalizations, and advance care planning communication and documentation. Intervention implementation will be assessed using a mixed-methods approach including a qualitative assessment of participants' and intervention personnel experiences and a quantitative assessment of care delivery, resources, and cost.

Discussion: The ADAPT trial studies an innovative intervention designed to improve quality of life for veterans with common, burdensome illnesses by targeting key underlying factors-symptoms and depression-that impair quality of life but persist despite disease-specific therapies. Leveraging the skills of affiliate health providers with physician supervision will extend the reach of palliative care and improve quality of life for those with advanced disease within routine outpatient care. The hybrid effectiveness/implementation design of the ADAPT trial will shorten the time to broader dissemination if effective and create avenues for future research.

Trial registration: ClinicalTrials.gov, NCT02713347 . Registered March 19, 2016.

Keywords: Heart failure; chronic obstructive pulmonary disease; interstitial lung disease; palliative care; quality of life.

Conflict of interest statement

The authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Conceptual model for the ADAPT trial and proposed intervention effects
Fig. 2
Fig. 2
Flowchart of the ADAPT study

References

    1. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL. Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manag. 2008;35(6):594–603. doi: 10.1016/j.jpainsymman.2007.06.007.
    1. Janssen DJ, Franssen FM, Wouters EF, Schols JM, Spruit MA. Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Qual Life Res. 2011;20(10):1679–1688. doi: 10.1007/s11136-011-9892-9.
    1. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manag. 2009;38(1):115–123. doi: 10.1016/j.jpainsymman.2008.07.006.
    1. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005;60(7):588–594. doi: 10.1136/thx.2004.035220.
    1. Yount SE, Beaumont JL, Chen SY, Kaiser K, Wortman K, Van Brunt DL, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung. 2016;194(2):227–234. doi: 10.1007/s00408-016-9850-y.
    1. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J. 2001;17(5):954–961. doi: 10.1183/09031936.01.17509540.
    1. Swigris JJ, Streiner DL, Brown KK, Belkin A, Green KE, Wamboldt FS, et al. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014;108(1):181–188. doi: 10.1016/j.rmed.2013.12.009.
    1. Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest. 2005;127(1):284–294. doi: 10.1378/chest.127.1.284.
    1. Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS. A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Chest. 2014;145(6):1333–1338. doi: 10.1378/chest.13-1984.
    1. Bentsen SB, Rustoen T, Miaskowski C. Prevalence and characteristics of pain in patients with chronic obstructive pulmonary disease compared to the Norwegian general population. J Pain. 2011;12(5):539–545. doi: 10.1016/j.jpain.2010.10.014.
    1. Borge CR, Wahl AK, Moum T. Pain and quality of life with chronic obstructive pulmonary disease. Heart Lung. 2011;40(3):e90–101. doi: 10.1016/j.hrtlng.2010.10.009.
    1. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13(8):643–648. doi: 10.1016/j.cardfail.2007.05.005.
    1. Holland AE, Fiore JF, Jr, Bell EC, Goh N, Westall G, Symons K, et al. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014;19(8):1215–1221. doi: 10.1111/resp.12360.
    1. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–1537. doi: 10.1016/j.jacc.2006.06.055.
    1. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211.
    1. Ng TP, Niti M, Fones C, Yap KB, Tan WC. Co-morbid association of depression and COPD: a population-based study. Respir Med. 2009;103(6):895–901. doi: 10.1016/j.rmed.2008.12.010.
    1. Hilmarsen CW, Wilke S, Engan H, Spruit MA, Rodenburg J, Janssen DJ, et al. Impact of symptoms of anxiety and depression on COPD Assessment Test scores. Eur Respir J. 2014;43(3):898–900. doi: 10.1183/09031936.00163913.
    1. Cully JA, Phillips LL, Kunik ME, Stanley MA, Deswal A. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med. 2010;36(2):70–76. doi: 10.1080/08964280903521297.
    1. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardpulm Rehabil. 2001;21(2):80–86. doi: 10.1097/00008483-200103000-00004.
    1. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742. doi: 10.1056/NEJMoa1000678.
    1. Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009;27(34):5816–5822. doi: 10.1200/JCO.2009.23.7420.
    1. Gade G, Venohr I, Conner D, McGrady K, Beane J, Richardson RH, et al. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med. 2008;11(2):180–190. doi: 10.1089/jpm.2007.0055.
    1. Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19(3):14–27. doi: 10.1097/00012272-199703000-00003.
    1. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65. doi: 10.1001/jama.1995.03520250075037.
    1. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–226. doi: 10.1097/MLR.0b013e3182408812.
    1. Jones Rhodes WC, Ritzwoller DP, Glasgow RE. Stakeholder perspectives on costs and resource expenditures: tools for addressing economic issues most relevant to patients, providers, and clinics. Transl Behav Med. 2018;8(5):675–682. doi: 10.1093/tbm/ibx003.
    1. Wang L, Porter B, Maynard C, Evans G, Bryson C, Sun H, et al. Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration. Med Care. 2013;51(4):368–373. doi: 10.1097/MLR.0b013e31827da95a.
    1. Brown AW, Fischer CP, Shlobin OA, Buhr RG, Ahmad S, Weir NA, et al. Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study. Chest. 2015;147(1):173–179. doi: 10.1378/chest.13-2424.
    1. Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest. 2016;149(5):1205–1214. doi: 10.1016/j.chest.2015.12.026.
    1. Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer. 2014;120(18):2902–2909. doi: 10.1002/cncr.28758.
    1. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006;113(23):2713–23. doi: 10.1161/CIRCULATIONAHA.105.577577.
    1. Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, et al. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res. 2011;11:37. doi: 10.1186/1472-6963-11-37.
    1. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997;127(12):1097–1102. doi: 10.7326/0003-4819-127-12-199712150-00008.
    1. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–2620. doi: 10.1056/NEJMoa1003955.
    1. Workers NAoS . NASW Standards for Palliative & End of Life Care. Washington, DC: NASW Press; 2004.
    1. Turvey CL, Klein DM. Remission from depression comorbid with chronic illness and physical impairment. Am J Psychiatry. 2008;165(5):569–574. doi: 10.1176/appi.ajp.2007.07081224.
    1. Bekelman DB, Johnson-Koenke R, Ahluwalia SC, Walling AM, Peterson J, Sudore RL. Development and feasibility of a structured goals of care communication guide. J Palliat Med. 2017;20(9):1004–1012. doi: 10.1089/jpm.2016.0383.
    1. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79. doi: 10.1186/1477-7525-1-79.
    1. Steinhauser KE, Arnold RM, Olsen MK, Lindquist J, Hays J, Wood LL, et al. Comparing three life-limiting diseases: does diagnosis matter or is sick, sick? J Pain Symptom Manag. 2011;42(3):331–341. doi: 10.1016/j.jpainsymman.2010.11.006.
    1. Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721–1730. doi: 10.1016/S0140-6736(13)62416-2.
    1. Badger TA, Segrin C, Meek P. Development and validation of an instrument for rapidly assessing symptoms: the general symptom distress scale. J Pain Symptom Manag. 2011;41(3):535–548. doi: 10.1016/j.jpainsymman.2010.06.011.
    1. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1–3):163–173. doi: 10.1016/j.jad.2008.06.026.
    1. Steinhauser KE, Clipp EC, Bosworth HB, McNeilly M, Christakis NA, Voils CI, et al. Measuring quality of life at the end of life: validation of the QUAL-E. Palliat Support Care. 2004;2(1):3–14. doi: 10.1017/S1478951504040027.
    1. Lo C, Burman D, Swami N, Gagliese L, Rodin G, Zimmermann C. Validation of the QUAL-EC for assessing quality of life in patients with advanced cancer. Eur J Cancer. 2011;47(4):554–560. doi: 10.1016/j.ejca.2010.10.027.
    1. Spertus JA, Jones PG. Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes. 2015;8(5):469–476. doi: 10.1161/CIRCOUTCOMES.115.001958.
    1. Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P, et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150(4):707–715. doi: 10.1016/j.ahj.2004.12.010.
    1. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752–756. doi: 10.1016/j.jacc.2005.11.021.
    1. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13. doi: 10.1186/1477-7525-1-13.
    1. Reda AA, Kotz D, Kocks JW, Wesseling G, van Schayck CP. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med. 2010;104(11):1675–1682. doi: 10.1016/j.rmed.2010.04.023.
    1. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804–810. doi: 10.1136/thoraxjnl-2012-201581.
    1. Sudore RL, Stewart AL, Knight SJ, McMahan RD, Feuz M, Miao Y, et al. Development and validation of a questionnaire to detect behavior change in multiple advance care planning behaviors. PLoS One. 2013;8(9):e72465. doi: 10.1371/journal.pone.0072465.
    1. Sudore RL, Heyland DK, Barnes DE, Howard M, Fassbender K, Robinson CA, et al. Measuring advance care planning: optimizing the Advance Care Planning Engagement Survey. J Pain Symptom Manag. 2017;53(4):669–81 e8. doi: 10.1016/j.jpainsymman.2016.10.367.
    1. Teno JM, Fisher ES, Hamel MB, Coppola K, Dawson NV. Medical care inconsistent with patients' treatment goals: association with 1-year Medicare resource use and survival. J Am Geriatr Soc. 2002;50(3):496–500. doi: 10.1046/j.1532-5415.2002.50116.x.
    1. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi: 10.1186/1748-5908-4-50.
    1. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag. 2002;24(6):547–561. doi: 10.1016/S0885-3924(02)00529-8.
    1. Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, et al. Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018;197(5):670–673. doi: 10.1164/rccm.201706-1154LE.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다